Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Wakimoto

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Journal of Cardiovascular Electrophysiology|September 3, 2010
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutationRonny Alcalai, Hiroko Wakimoto, Michael Arad, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2002
Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 geneHiroko Wakimoto, Colin T Maguire, Megan C Sherwood, et al.
Circulation. Heart Failure|October 8, 2009
Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factorsHector R Mobine, Aaron B Baker, Libin Wang, et al.
Circulation. Arrhythmia and Electrophysiology|August 1, 2015
Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense MutationRajib Chowdhury, Hassan Ashraf, Michelle Melanson, et al.
Journal of Molecular and Cellular Cardiology Plus|December 25, 2023
Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodelingIrina Zalivina, Temo Barwari, Xiaoke Yin, et al.
International Journal of Cardiology|June 15, 2004
Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndromeNaomi Izumida, Yuh Asano, Shouzaburoh Doi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningiomaYoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, et al.
Frontiers in Cardiovascular Medicine|July 12, 2021
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With <i>Lmna</i> MutationKenji Onoue, Hiroko Wakimoto, Jiangming Jiang, et al.
Nature Communications|July 4, 2019
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastomaJian-Fang Ning, Monica Stanciu, Melissa R Humphrey, et al.
The Journal of Clinical Investigation|November 3, 2010
Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutationPeng-Chieh Chen, Hiroko Wakimoto, David Conner, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Electrophysiology|September 3, 2010
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutationRonny Alcalai, Hiroko Wakimoto, Michael Arad, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2002
Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 geneHiroko Wakimoto, Colin T Maguire, Megan C Sherwood, et al.
Circulation. Heart Failure|October 8, 2009
Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factorsHector R Mobine, Aaron B Baker, Libin Wang, et al.
Circulation. Arrhythmia and Electrophysiology|August 1, 2015
Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense MutationRajib Chowdhury, Hassan Ashraf, Michelle Melanson, et al.
Journal of Molecular and Cellular Cardiology Plus|December 25, 2023
Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodelingIrina Zalivina, Temo Barwari, Xiaoke Yin, et al.
International Journal of Cardiology|June 15, 2004
Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndromeNaomi Izumida, Yuh Asano, Shouzaburoh Doi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningiomaYoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, et al.
Frontiers in Cardiovascular Medicine|July 12, 2021
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With <i>Lmna</i> MutationKenji Onoue, Hiroko Wakimoto, Jiangming Jiang, et al.
Nature Communications|July 4, 2019
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastomaJian-Fang Ning, Monica Stanciu, Melissa R Humphrey, et al.
The Journal of Clinical Investigation|November 3, 2010
Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutationPeng-Chieh Chen, Hiroko Wakimoto, David Conner, et al.
Pageof 7